Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Third Rock Ventures
Biotech
Third Rock, Novo Holdings-backed Clasp hooks $150M series A
A new immuno-oncology biotech has emerged, clasping $150 million that will go toward developing next-gen T cell engagers.
Gabrielle Masson
Mar 20, 2024 7:00am
Pfizer's migraine market chief joins Apnimed—Chutes & Ladders
Jan 26, 2024 9:30am
Third Rock adds 3 new venture partners, including Karuna’s Paul
Jan 25, 2024 10:35am
Rapport finds the right words to talk investors into $150M more
Aug 23, 2023 6:00am
Septerna snags $150M series B for next-gen GPCR drugs
Jul 11, 2023 7:00am
Cure Ventures unveils inaugural $350M fund
Apr 4, 2023 7:00am